Genes Tech Group Holdings Beheer
Beheer criteriumcontroles 4/4
Genes Tech Group Holdings' CEO is Ming-Hsiang Yang, appointed in Dec 2009, has a tenure of 14.92 years. total yearly compensation is NT$6.04M, comprised of 67.6% salary and 32.4% bonuses, including company stock and options. directly owns 3.8% of the company’s shares, worth HK$3.23M. The average tenure of the management team and the board of directors is 10.2 years and 7.4 years respectively.
Belangrijke informatie
Ming-Hsiang Yang
Algemeen directeur
NT$6.0m
Totale compensatie
Percentage CEO-salaris | 67.6% |
Dienstverband CEO | 14.9yrs |
Eigendom CEO | 3.8% |
Management gemiddelde ambtstermijn | 10.2yrs |
Gemiddelde ambtstermijn bestuur | 7.4yrs |
Recente managementupdates
Recent updates
Lacklustre Performance Is Driving Genes Tech Group Holdings Company Limited's (HKG:8257) Low P/S
Oct 03Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20Genes Tech Group Holdings (HKG:8257) Has More To Do To Multiply In Value Going Forward
Jun 05There's No Escaping Genes Tech Group Holdings Company Limited's (HKG:8257) Muted Revenues Despite A 27% Share Price Rise
Jun 05Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Stock's 37% Jump Looks Justified
Apr 17Returns On Capital Are Showing Encouraging Signs At Genes Tech Group Holdings (HKG:8257)
Feb 22Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Shares Find Their Feet
Dec 20Why We Like The Returns At Genes Tech Group Holdings (HKG:8257)
Oct 19Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Returns On Capital Are A Standout For Genes Tech Group Holdings (HKG:8257)
Jul 11Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19Calculating The Fair Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Mar 01Genes Tech Group Holdings (HKG:8257) Might Be Having Difficulty Using Its Capital Effectively
Dec 27Estimating The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Nov 30These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Returns On Capital At Genes Tech Group Holdings (HKG:8257) Paint A Concerning Picture
Sep 06Genes Tech Group Holdings' (HKG:8257) Returns On Capital Not Reflecting Well On The Business
May 26Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has Some Way To Go To Become A Multi-Bagger
Feb 09Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26We Think Shareholders Will Probably Be Generous With Genes Tech Group Holdings Company Limited's (HKG:8257) CEO Compensation
Jun 18Returns On Capital At Genes Tech Group Holdings (HKG:8257) Have Stalled
May 26Why Genes Tech Group Holdings Company Limited (HKG:8257) Is A Dividend Rockstar
Apr 08Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Mar 18Returns On Capital - An Important Metric For Genes Tech Group Holdings (HKG:8257)
Feb 23Is Genes Tech Group Holdings Company Limited's(HKG:8257) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 19A Look At The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Dec 16Will Genes Tech Group Holdings (HKG:8257) Repeat Its Return Growth Of The Past?
Nov 24Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | NT$53m |
Mar 31 2024 | n/a | n/a | NT$81m |
Dec 31 2023 | NT$6m | NT$4m | NT$91m |
Sep 30 2023 | n/a | n/a | -NT$109m |
Jun 30 2023 | n/a | n/a | -NT$77m |
Mar 31 2023 | n/a | n/a | -NT$75m |
Dec 31 2022 | NT$1m | NT$4k | -NT$80m |
Sep 30 2022 | n/a | n/a | NT$111m |
Jun 30 2022 | n/a | n/a | NT$106m |
Mar 31 2022 | n/a | n/a | NT$72m |
Dec 31 2021 | NT$5m | NT$4m | NT$79m |
Sep 30 2021 | n/a | n/a | NT$111m |
Jun 30 2021 | n/a | n/a | NT$95m |
Mar 31 2021 | n/a | n/a | NT$118m |
Dec 31 2020 | NT$5m | NT$4m | NT$144m |
Sep 30 2020 | n/a | n/a | NT$153m |
Jun 30 2020 | n/a | n/a | NT$164m |
Mar 31 2020 | n/a | n/a | NT$202m |
Dec 31 2019 | NT$5m | NT$4m | NT$179m |
Sep 30 2019 | n/a | n/a | NT$161m |
Jun 30 2019 | n/a | n/a | NT$132m |
Mar 31 2019 | n/a | n/a | NT$89m |
Dec 31 2018 | NT$5m | NT$3m | NT$56m |
Sep 30 2018 | n/a | n/a | NT$38m |
Jun 30 2018 | n/a | n/a | NT$43m |
Mar 31 2018 | n/a | n/a | NT$26m |
Dec 31 2017 | NT$5m | NT$4m | NT$37m |
Compensatie versus markt: Ming-Hsiang's total compensation ($USD188.94K) is about average for companies of similar size in the Hong Kong market ($USD235.07K).
Compensatie versus inkomsten: Ming-Hsiang's compensation has been consistent with company performance over the past year.
CEO
Ming-Hsiang Yang (53 yo)
14.9yrs
Tenure
NT$6,037,000
Compensatie
Mr. Ming-Hsiang Yang serves as Chairman of Genes Tech Group Holdings Company Limited and has been its Chief Executive Officer since December 2009. Prior to joining the Group, Mr. Yang worked in Chung Mei P...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | 14.9yrs | NT$6.04m | 3.8% HK$ 3.2m | |
CFO, Compliance Officer | 13.7yrs | NT$5.64m | 2.91% HK$ 2.5m | |
Executive Director | less than a year | geen gegevens | 0.24% HK$ 208.3k | |
Company Secretary | 6.8yrs | geen gegevens | geen gegevens |
10.2yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: 8257's management team is seasoned and experienced (10.2 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | 8.4yrs | NT$6.04m | 3.8% HK$ 3.2m | |
CFO, Compliance Officer | 8.3yrs | NT$5.64m | 2.91% HK$ 2.5m | |
Executive Director | less than a year | geen gegevens | 0.24% HK$ 208.3k | |
Independent Non-Executive Director | 7.4yrs | NT$954.00k | geen gegevens | |
Independent Non-Executive Director | 7.4yrs | NT$954.00k | geen gegevens | |
Independent Non-Executive Director | 7.4yrs | NT$954.00k | geen gegevens |
7.4yrs
Gemiddelde duur
49.5yo
Gemiddelde leeftijd
Ervaren bestuur: 8257's board of directors are considered experienced (7.4 years average tenure).